SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-059898
Filing Date
2014-08-12
Accepted
2014-08-12 16:04:43
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-13963_110q.htm 10-Q 826715
2 EX-31.1 a14-13963_1ex31d1.htm EX-31.1 9105
3 EX-31.2 a14-13963_1ex31d2.htm EX-31.2 9473
4 EX-32.1 a14-13963_1ex32d1.htm EX-32.1 5318
5 EX-32.2 a14-13963_1ex32d2.htm EX-32.2 5322
  Complete submission text file 0001104659-14-059898.txt   3825697

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fate-20140630.xml EX-101.INS 368446
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fate-20140630.xsd EX-101.SCH 39396
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fate-20140630_cal.xml EX-101.CAL 44520
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fate-20140630_def.xml EX-101.DEF 145388
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT fate-20140630_lab.xml EX-101.LAB 485015
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fate-20140630_pre.xml EX-101.PRE 288148
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-36076 | Film No.: 141033981
SIC: 2836 Biological Products, (No Diagnostic Substances)